Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS

被引:379
|
作者
Mahley, Robert W. [1 ,2 ,3 ,4 ,5 ]
Weisgraber, Karl H. [1 ,2 ,4 ,5 ]
Huang, Yadong [1 ,2 ,4 ]
机构
[1] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
[2] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
cholesterol; neurodegeneration; HIV; coronary heart disease; LDL receptor; dysbetalipoproteinemia; heparan sulfate proteoglycans; infectious diseases; evolution; LOW-DENSITY LIPOPROTEINS; AMYLOID-BETA PEPTIDE; CELL-SURFACE RECEPTORS; AMINO-ACID-SEQUENCE; DOMAIN INTERACTION; TRANSGENIC MICE; III HYPERLIPOPROTEINEMIA; HUMAN FIBROBLASTS; NEURONAL CELLS; REMNANT LIPOPROTEINS;
D O I
10.1194/jlr.R800069-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein (apo) E has roles beyond lipoprotein metabolism. The detrimental effects of apoE4 in cardiovascular, neurological, and infectious diseases correlate with its structural features (e.g., domain interaction) that distinguish it from apoE3 and apoE2. Structure/function studies revealed that apoE2 is severely defective in LDL receptor binding because of a structural difference that alters the receptor binding region and helped unravel the mechanism of type III hyperlipoproteinemia. ApoE4 is the major genetic risk factor for Alzheimer's disease and sets the stage for neuropathological disorders precipitated by genetic, metabolic, and environmental stressors. ApoE also influences susceptibility to parasitic, bacterial, and viral infections. In HIV-positive patients, apoE4 homozygosity hastens progression to AIDS and death and increases susceptibility to opportunistic infections. jlr The next phase in our understanding of apoE will be characterized by clinical intervention to prevent or reverse the detrimental effects of apoE4 by modulating its structure or blocking the pathological processes it mediates.-Mahley, R. W., K. H. Weisgraber, and Y. Huang. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J. Lipid Res. 2009. S183-S188.
引用
收藏
页码:S183 / S188
页数:6
相关论文
共 50 条
  • [1] APOLIPOPROTEIN E: STRUCTURE DETERMINES FUNCTION-FROM ATHEROSCLEROSIS TO ALZHEIMER'S DISEASE TO AIDS
    Mahley, R.
    Weisgraber, K.
    Huang, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [2] Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond
    Mahley, RW
    Huang, YD
    CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) : 207 - 217
  • [3] Apolipoprotein E - Structure, function, and possible roles in Alzheimer's disease
    Mahley, RW
    Nathan, BP
    Pitas, RE
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 139 - 145
  • [4] Implication of apolipoprotein e polymorphisms in the atherosclerosis and Alzheimer's disease physiopathology
    Narvaez Lopez, Edgar Jonathan
    Bravo Pelaez, Jose Andres
    Almeida Lozano, Karen Alexandra
    Alvarez Rivera, Cristian Geovanny
    Mendoza Argandona, Cesar Augusto
    Morales Sanchez, Alex Marcelo
    Godos Rivera, Digna Tatiana
    Del Salto Ocana, Tatiana Elizabeth
    Catota Camacho, Maria Magdalena
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (02): : 97 - 102
  • [5] Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
    Hofman, A
    Ott, A
    Breteler, MMB
    Bots, ML
    Slooter, AJC
    vanHarskamp, F
    vanDuijn, CN
    Van Broeckhoven, C
    Grobbee, DE
    LANCET, 1997, 349 (9046): : 151 - 154
  • [6] Apolipoprotein E and Alzheimer's disease
    Benjamin R.Troutwine
    Laylan Hamid
    Colton R.Lysaker
    Taylor A.Strope
    Heather M.Wilkins
    Acta Pharmaceutica Sinica B, 2022, 12 (02) : 496 - 510
  • [7] Apolipoprotein E and Alzheimer's disease
    Strittmatter, WJ
    Roses, AD
    ANNUAL REVIEW OF NEUROSCIENCE, 1996, 19 : 53 - 77
  • [8] Apolipoprotein E and Alzheimer's disease
    Stephens, D
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1996, 116 (01): : 41 - 43
  • [9] Apolipoprotein E and Alzheimer's disease
    Strittmatter, WJ
    ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 91 - 92
  • [10] Apolipoprotein E and Alzheimer's disease
    Troutwine, Benjamin R.
    Hamid, Laylan
    Lysaker, Colton R.
    Strope, Taylor A.
    Wilkins, Heather M.
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 496 - 510